About Natera, Inc.
https://www.natera.comNatera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide.
CEO
Steven Leonard Chapman
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 382
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Canaccord Genuity
Buy
BTIG
Buy
UBS
Buy
Goldman Sachs
Buy
Guggenheim
Buy
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:12.39M
Value:$2.96B
PRICE T ROWE ASSOCIATES INC /MD/
Shares:11.95M
Value:$2.86B
JPMORGAN CHASE & CO
Shares:11.63M
Value:$2.78B
Summary
Showing Top 3 of 789
About Natera, Inc.
https://www.natera.comNatera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $592.18M ▲ | $481.96M ▲ | $-87.54M ▲ | -14.78% ▲ | $-0.64 ▲ | $-76.43M ▲ |
| Q2-2025 | $546.6M ▲ | $457.44M ▲ | $-100.94M ▼ | -18.47% ▼ | $-0.74 ▼ | $-89.78M ▼ |
| Q1-2025 | $501.83M ▲ | $396.39M ▲ | $-66.94M ▼ | -13.34% ▼ | $-0.5 ▼ | $-56.52M ▼ |
| Q4-2024 | $476.06M ▲ | $364.38M ▲ | $-53.77M ▼ | -11.29% ▼ | $-0.41 ▼ | $-46.04M ▼ |
| Q3-2024 | $439.76M | $311.08M | $-31.59M | -7.18% | $-0.26 | $-19.52M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.04B ▲ | $1.82B ▲ | $569.29M ▲ | $1.25B ▲ |
| Q2-2025 | $1.02B ▲ | $1.76B ▲ | $510.88M ▲ | $1.25B ▲ |
| Q1-2025 | $991.6M ▲ | $1.73B ▲ | $492.69M ▲ | $1.24B ▲ |
| Q4-2024 | $968.28M ▲ | $1.66B ▲ | $465.31M ▼ | $1.2B ▲ |
| Q3-2024 | $922.33M | $1.59B | $712.42M | $878.52M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-87.54M ▲ | $59.39M ▲ | $-19.91M ▲ | $1.94M ▼ | $41.42M ▲ | $24.48M ▲ |
| Q2-2025 | $-100.94M ▼ | $37.57M ▼ | $-23.9M ▼ | $12.58M ▲ | $26.25M ▼ | $11.68M ▼ |
| Q1-2025 | $-66.94M ▼ | $44.45M ▼ | $-16.82M ▼ | $544K ▼ | $28.18M ▼ | $22.64M ▼ |
| Q4-2024 | $-53.77M ▼ | $52.89M ▲ | $-11.12M ▼ | $10.97M ▲ | $52.74M ▼ | $34.77M ▼ |
| Q3-2024 | $-31.59M | $51.79M | $42.54M | $1.72M | $96.05M | $35.47M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Licensing and other | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Product | $880.00M ▲ | $500.00M ▼ | $540.00M ▲ | $590.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Americas excluding US | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Asia Pacific and Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Europe Middle East India Africa | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 UNITED STATES | $470.00M ▲ | $580.00M ▲ | $540.00M ▼ | $490.00M ▼ |
CEO
Steven Leonard Chapman
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 382
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Canaccord Genuity
Buy
BTIG
Buy
UBS
Buy
Goldman Sachs
Buy
Guggenheim
Buy
Evercore ISI Group
Outperform
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:12.39M
Value:$2.96B
PRICE T ROWE ASSOCIATES INC /MD/
Shares:11.95M
Value:$2.86B
JPMORGAN CHASE & CO
Shares:11.63M
Value:$2.78B
Summary
Showing Top 3 of 789